Published in J Invest Dermatol on April 01, 2003
Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling. Am J Pathol (2007) 1.17
G protein-coupled receptor kinase 2 positively regulates epithelial cell migration. EMBO J (2008) 1.14
A comparison of epithelial-to-mesenchymal transition and re-epithelialization. Semin Cancer Biol (2012) 1.00
The expression of sphingosine kinase-1 in head and neck carcinoma. Cells Tissues Organs (2010) 0.95
The immunomodulator FTY720 and its phosphorylated derivative activate the Smad signalling cascade and upregulate connective tissue growth factor and collagen type IV expression in renal mesangial cells. Br J Pharmacol (2006) 0.95
Vasculogenic cytokines in wound healing. Biomed Res Int (2013) 0.95
Heterologous desensitization of the sphingosine-1-phosphate receptors by purinoceptor activation in renal mesangial cells. Br J Pharmacol (2004) 0.93
A novel role of a lipid species, sphingosine-1-phosphate, in epithelial innate immunity. Mol Cell Biol (2012) 0.93
Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models. Oncogene (2011) 0.92
Ceramide signaling in mammalian epidermis. Biochim Biophys Acta (2013) 0.92
Loss of sphingosine kinase-1 in carcinoma cells increases formation of reactive oxygen species and sensitivity to doxorubicin-induced DNA damage. Br J Pharmacol (2011) 0.90
Sphingosine 1-phosphate potentiates human lung fibroblast chemotaxis through the S1P2 receptor. Am J Respir Cell Mol Biol (2008) 0.88
Sphingosine-1-phosphate phosphatase 1 regulates keratinocyte differentiation and epidermal homeostasis. J Biol Chem (2013) 0.83
The role of epidermal sphingolipids in dermatologic diseases. Lipids Health Dis (2016) 0.81
Analysis of ceramide metabolites in differentiating epidermal keratinocytes treated with calcium or vitamin C. Nutr Res Pract (2011) 0.79
C/EBPδ gene targets in human keratinocytes. PLoS One (2010) 0.79
Paradoxical effects of sphingosine-1-phosphate. J Invest Dermatol (2003) 0.76
Role of Ceramide from Glycosphingolipids and Its Metabolites in Immunological and Inflammatory Responses in Humans. Mediators Inflamm (2015) 0.75
A hypothesis concerning a potential involvement of ceramide in apoptosis and acantholysis induced by pemphigus autoantibodies. Dermatol Res Pract (2010) 0.75
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest (2004) 2.36
Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J Clin Invest (2013) 2.08
Human defensins. J Mol Med (Berl) (2005) 1.66
Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration. J Invest Dermatol (2009) 1.60
Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-beta-induced cell responses. J Biol Chem (2004) 1.48
Rapidly regrowing lipoma in lipomeningomyelocele: a case report. Childs Nerv Syst (2009) 1.46
Age-specific eNOS polymorphisms in moyamoya disease. Childs Nerv Syst (2011) 1.46
Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nat Med (2013) 1.36
Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling. Am J Pathol (2007) 1.17
Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis. Am J Respir Cell Mol Biol (2009) 1.13
Involvement of the ABC-transporter ABCC1 and the sphingosine 1-phosphate receptor subtype S1P(3) in the cytoprotection of human fibroblasts by the glucocorticoid dexamethasone. J Mol Med (Berl) (2009) 1.06
Resective pediatric epilepsy surgery in Lennox-Gastaut syndrome. Pediatrics (2009) 1.06
Involvement of Smad signaling in sphingosine 1-phosphate-mediated biological responses of keratinocytes. J Biol Chem (2004) 1.06
Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease. Am J Hum Genet (2010) 1.05
Treatment option for arachnoid cysts. Childs Nerv Syst (2009) 1.05
Neuroimaging in identifying focal cortical dysplasia and prognostic factors in pediatric and adolescent epilepsy surgery. Epilepsia (2011) 1.03
The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death. Br J Pharmacol (2014) 1.01
Endoscopic disconnection for hypothalamic hamartoma with intractable seizure. Report of four cases. J Neurosurg (2004) 1.00
Nanoparticles for skin penetration enhancement--a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles. Eur J Pharm Biopharm (2008) 0.99
The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization. PLoS One (2012) 0.98
A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors. Int J Radiat Oncol Biol Phys (2012) 0.97
Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology (2005) 0.97
Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52. J Immunol (2005) 0.97
Antioxidant effect of Inonotus obliquus. J Ethnopharmacol (2005) 0.97
Association of the miR-146aC>G, miR-196a2C>T, and miR-499A>G polymorphisms with moyamoya disease in the Korean population. Neurosci Lett (2012) 0.95
Sphingosine 1-phosphate restrains insulin-mediated keratinocyte proliferation via inhibition of Akt through the S1P2 receptor subtype. J Invest Dermatol (2008) 0.95
Treatment and outcomes of primary intracranial teratoma. Childs Nerv Syst (2009) 0.95
Isolation of glioma cancer stem cells in relation to histological grades in glioma specimens. Childs Nerv Syst (2012) 0.94
State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. ALTEX (2014) 0.94
Risk factors for postoperative ischemic complications in patients with moyamoya disease. J Neurosurg (2005) 0.93
Synergistic effects of dexamethasone and quinolones on human-derived tendon cells. Int J Antimicrob Agents (2010) 0.92
The history of ependymoma management. Childs Nerv Syst (2009) 0.92
Factors contributing improvement of syringomyelia and surgical outcome in type I Chiari malformation. Childs Nerv Syst (2008) 0.91
Different skin thinning potential of equipotent medium-strength glucocorticoids. Skin Pharmacol Appl Skin Physiol (2002) 0.90
Treatment failure in intracranial primary germinomas. Childs Nerv Syst (2007) 0.90
Factors contributing to resectability and seizure outcomes in 44 patients with ganglioglioma. Clin Neurol Neurosurg (2008) 0.89
Lysophospholipid receptor-mediated calcium signaling in human keratinocytes. J Invest Dermatol (2008) 0.89
Sphingosine-1-phosphate inhibits human keratinocyte proliferation via Akt/protein kinase B inactivation. Cell Signal (2004) 0.88
Mixed or metachronous germ-cell tumor? Childs Nerv Syst (2006) 0.88
3D-wound healing model: influence of morphine and solid lipid nanoparticles. J Biotechnol (2010) 0.88
Long-term suppression of tyrosinase by terrein via tyrosinase degradation and its decreased expression. Exp Dermatol (2009) 0.88
Low-dose craniospinal irradiation as a definitive treatment for intracranial germinoma. Radiother Oncol (2008) 0.88
Distraction vs remodeling surgery for craniosynostosis. Childs Nerv Syst (2006) 0.88
What should we do with a discontinued shunt? Childs Nerv Syst (2009) 0.88
The role of sphingosine-1-phosphate receptor modulators in the prevention of transplant rejection and autoimmune diseases. Curr Opin Investig Drugs (2009) 0.88
Influence of nanocarrier type and size on skin delivery of hydrophilic agents. Int J Pharm (2009) 0.87
Lysophosphatidic acid interacts with transforming growth factor-beta signaling to mediate keratinocyte growth arrest and chemotaxis. J Invest Dermatol (2004) 0.87
Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans. J Antimicrob Chemother (2005) 0.86
Glutathione prevented dopamine-induced apoptosis of melanocytes and its signaling. J Dermatol Sci (2007) 0.86
The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology. Arch Immunol Ther Exp (Warsz) (2006) 0.86
Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype. Diabetologia (2013) 0.86
Hallmarks of atopic skin mimicked in vitro by means of a skin disease model based on FLG knock-down. Altern Lab Anim (2011) 0.85
Cranioplasty Enhanced by Three-Dimensional Printing: Custom-Made Three-Dimensional-Printed Titanium Implants for Skull Defects. J Craniofac Surg (2016) 0.85
Sphingosine-1-phosphate signaling and the skin. Am J Clin Dermatol (2007) 0.85
Postoperative evaluation of moyamoya disease with perfusion-weighted MR imaging: initial experience. AJNR Am J Neuroradiol (2003) 0.85
SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions. Int J Pharm (2010) 0.85
17-Beta-estradiol inhibits transforming-growth-factor-beta-induced MCF-7 cell migration by Smad3-repression. Eur J Pharmacol (2006) 0.85
Expression of sphingosine-1-phosphate receptors and lysophosphatidic acid receptors on cultured and xenografted human colon, breast, melanoma, and lung tumor cells. Tumour Biol (2010) 0.85
Involvement of ERK AND p38 MAP kinase in AAPH-induced COX-2 expression in HaCaT cells. Chem Phys Lipids (2004) 0.85
Antiapoptotic action of 1alpha,25-dihydroxyvitamin D3 in primary human melanocytes. Melanoma Res (2003) 0.84
A thermosensitive morphine-containing hydrogel for the treatment of large-scale skin wounds. Int J Pharm (2013) 0.84
Cationic membrane-active peptides - anticancer and antifungal activity as well as penetration into human skin. Exp Dermatol (2014) 0.84
Moyamoya syndrome after radiation therapy: case reports. Pediatr Neurosurg (2011) 0.83
Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm Res (2007) 0.83
Receptor-selective retinoids for psoriasis: focus on tazarotene. Am J Clin Dermatol (2006) 0.83
Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis. J Dermatol Sci (2013) 0.83
Glucocorticoid receptor interactions with glucocorticoids: evaluation by molecular modeling and functional analysis of glucocorticoid receptor mutants. Steroids (2003) 0.83
Novel methods for the quantification of (2E)-hexadecenal by liquid chromatography with detection by either ESI QTOF tandem mass spectrometry or fluorescence measurement. Anal Chim Acta (2012) 0.83
Sphingosine 1-phosphate modulates antigen capture by murine Langerhans cells via the S1P2 receptor subtype. PLoS One (2012) 0.83
Dipeptides Inhibit Melanin Synthesis in Mel-Ab Cells through Down-Regulation of Tyrosinase. Korean J Physiol Pharmacol (2012) 0.83
Sphingosine kinase-1 (SphK-1) regulates Mycobacterium smegmatis infection in macrophages. PLoS One (2010) 0.83
Isolation of tumor spheres and mesenchymal stem-like cells from a single primitive neuroectodermal tumor specimen. Childs Nerv Syst (2013) 0.83
Simultaneous endoscopic third ventriculostomy and ventriculoperitoneal shunt for infantile hydrocephalus. Childs Nerv Syst (2007) 0.82
Treatment modalities for intractable epilepsy in hypothalamic hamartoma. Adv Tech Stand Neurosurg (2012) 0.82
Effects of vitamin C vs. multivitamin on melanogenesis: comparative study in vitro and in vivo. Int J Dermatol (2010) 0.82
Sphingosine-1-phosphate modulates dendritic cell function: focus on non-migratory effects in vitro and in vivo. Cell Physiol Biochem (2014) 0.82
Morphine stimulates cell migration of oral epithelial cells by delta-opioid receptor activation. PLoS One (2012) 0.82
Decreased concentration and enhanced metabolism of sphingosine-1-phosphate in lesional skin of dogs with atopic dermatitis: disturbed sphingosine-1-phosphate homeostasis in atopic dermatitis. J Invest Dermatol (2010) 0.82
Involvement of mTOR signaling in sphingosylphosphorylcholine-induced hypopigmentation effects. J Biomed Sci (2011) 0.82
Validation of the Pediatric Functional Assessment of Cancer Therapy Questionnaire (Version 2.0) in brain tumor survivors aged 13 years and older. J Pain Symptom Manage (2010) 0.82
The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y(2)-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation. J Mol Med (Berl) (2011) 0.82
17-year-old girl with headache and complex partial seizure. Brain Pathol (2010) 0.82
Divergent role of sphingosine 1-phosphate on insulin resistance. Cell Physiol Biochem (2014) 0.82
Effective inhibition of acid and neutral ceramidases by novel B-13 and LCL-464 analogues. Bioorg Med Chem (2012) 0.82
Changes in the biological characteristics of glioma cancer stem cells after serial in vivo subtransplantation. Childs Nerv Syst (2012) 0.82
Beta-catenin promoter polymorphism is associated with asthma risk in Korean subjects. Clin Biochem (2012) 0.82
Sphingosine 1-phosphate mediates chemotaxis of human primary fibroblasts via the S1P-receptor subtypes S1P₁ and S1P₃ and Smad-signalling. Cytoskeleton (Hoboken) (2010) 0.82
Leucine-rich glioma inactivated 3 induces neurite outgrowth through Akt and focal adhesion kinase. Neurochem Res (2010) 0.82
Changing the paradigm of 1-stage total callosotomy for the treatment of pediatric generalized epilepsy. J Neurosurg Pediatr (2008) 0.82